Neuroendocrine tumours trials in China

In China 62 Also abroad 244

62 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC (NESSIE)
Where
Beijing
Age
18 years to 75 years
People
30
Run by
Peking University
See details and how to joinNCT05165407
No phaseEnrolling by invitation
Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix
Where
Wuhan
Age
18 years to 75 years
People
20
Run by
Ding Ma
See details and how to joinNCT06810895
Phase 4Taking people
Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors
Where
Beijing
Age
18 years to 70 years
People
882
Run by
Beijing Tiantan Hospital
See details and how to joinNCT06679816
Phase 1/2Taking people
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.
Where
Beijing
Age
18 years to 75 years
People
78
Run by
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT06440057
Phase 2Taking people
A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)
Where
Beijing
Age
18 years and over
People
90
Run by
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
See details and how to joinNCT06505395
No phaseTaking people
Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLC
Where
Shanghai
Age
18 years and over
People
50
Run by
Fudan University
See details and how to joinNCT06369181
No phaseNot yet taking people in China
A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors
Where
Jinan
Age
18 years and over
People
500
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT06300216
Early phase 1Taking people
18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor
Where
Beijing
Age
1 year to 80 years
People
150
Run by
Peking Union Medical College Hospital
See details and how to joinNCT05069220
No phaseTaking people
Lateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric Excision
Where
Beijing
Age
18 years to 75 years
People
30
Run by
National Cancer Center, China
See details and how to joinNCT06279299
Phase 2Taking people
First- Line Treatment With Durvalumab Plus XELOX Chemotherapy in Advanced Gastrointestinal Neuroendocrine Carcinoma
Where
Beijing
Age
18 years to 75 years
People
22
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06070740
No phaseTaking people
Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors
Where
Guangzhou
Age
18 years to 70 years
People
300
Run by
Sun Yat-sen University
See details and how to joinNCT06015802
Phase 2Not yet taking people in China
Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms
Where
Shanghai
Age
18 years to 80 years
People
42
Run by
Fudan University
See details and how to joinNCT05316480